The Multiple Myeloma Channel is supported with funding from AbbVie (Platinum), Sanofi (Gold), Legend Biotech (Bronze), and through an educational grant from Alexion Pharma GmbH.
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
SOHO Italy 2020 | Managing unfit/frail MM patients
Daniele Derudas, MD, Businco Hospital, Cagliari, Italy, discusses the management of unfit/frail multiple myeloma patients in Italy, including defining fraility and fitness status in the disease population and using the appropriate therapies in these multiple myeloma patients, including low dosages or using agents with reduced toxicities in order to maintain quality of life. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
